A variation in bone alkaline phosphatase levels that correlates positively with bone loss and normal levels of aminoterminal propeptide of collagen I in girls with anorexia nervosa

Clinica Chimica Acta

Volumn 285, Issue 1-2, 1999, Pages 121-129

  Calero, Jesús A ^a   Muñoz, Maria Teresa ^b   Argente, Jesús ^b   Traba, Maria Luisa ^a   Méndez Dávila, Cioly ^a   García Moreno, Carmen ^a   De La Piedra, Concepción ^a,c  

^a Biochemistry Laboratory   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c Fund Jiménez Díaz   (Spain)

Author keywords

Anorexia nervosa; Bone alkaline phosphatase; Bone formation markers; Procollagen aminoterminal propeptide

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; PROCOLLAGEN;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; ARTICLE; BONE ATROPHY; BONE REMODELING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0345211528     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00114-X     Document Type: Article

References (15)

1. Delmas PD. Biochemical markers of bone remodelling in osteoporosis. In: Papapoulos SE, Lips P, Pols HAP, Johnston CC, Delmas PD, editors, Osteoporosis 96. International congress series, Vol. 1118, Amsterdam: Elsevier, 1996, pp. 191-204.
2. Schönau E, Rauch F. Markers of bone collagen metabolism - Problems and perspectives in paediatrics. Hormone Res 1997;48:50-9.
3. Dominguez-Cabrera C, Sosa M, Traba ML, Alvarez E, de la Piedra C. Biochemical markers of bone formation in the study of postmenopausal osteoporosis. Osteopor Int 1998;8:147-51.
4. Fledelius C, Johnsen AH, Cloos PAC, Bonde M, Qvist P. Characterization of urinary degradation products derived from type I collagen. J Biol Chem 1997;272:9755-63.
5. De la Piedra C, Calero JA, Traba ML, Asensio MD, Argente J, Muñoz MT. Urinary α and β C-telopeptides of collagen I: Clinical implications in bone remodelling in patients with anorexia nervosa. Osteopor Int (in press).
6. Maugars Y, Prost A. Osteoporosis in anorexia nervosa. Presse Med 1994;23:156-8.
7. Carmichael KA, Carmichael DH. Bone metabolism and osteopenia in eating disorders. Medicine 1995;74:254-67.
8. DSM IV Task Force. DSM-IV draft criteria 3/1/93, Washington DC: American Psychiatric Association, 1993.
9. Del Río L, Carrascosa A, Pons F, Gusinye M, Yeste D, Domenech FM. Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: changes related to age, sex and puberty. Pediatr Res 1994;35:362-6.
10. Panigrahi K, Delmas PD, Singer F et al. Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. Clin Chem 1994;40:822-8.
11. Melkko J, Kauppila S, Niemi S et al. Immunoassay for the intact aminoterminal propeptide of human type I procollagen. Clin Chem 1993;42:947-54.
12. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Inmunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994;39:635-40.
13. Stefanis N, Mackintosh C, Abraha HD, Treasure J, Moniz C. Dissociation of bone turnover in anorexia nervosa. Ann Clin Biochem 1998;35:709-16.
14. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996;81:3864-70.
15. Gordon C, Grace E, Emans SJ, Goodman E, Crawford MH, Leboff MS. Changes in bone turnover markers and menstrual function after short term oral DHEA in young women with anorexia nervosa. J Bone Miner Res 1999;14:136-45.